Journal of Gastroenterology

, Volume 50, Issue 10, pp 1041–1046 | Cite as

Risk of bleeding after endoscopic submucosal dissection for colorectal tumors in patients with continued use of low-dose aspirin

  • Yuki Ninomiya
  • Shiro OkaEmail author
  • Shinji Tanaka
  • Soki Nishiyama
  • Yuzuru Tamaru
  • Naoki Asayama
  • Kenjiro Shigita
  • Nana Hayashi
  • Kazuaki Chayama
Original Article—Alimentary Tract



Although Japanese guidelines proposed by the Japan Gastroenterological Endoscopy Society for endoscopic submucosal dissection (ESD) for colorectal tumors recommend continued use of low-dose aspirin (LDA), this strategy is controversial. It was our practice to interrupt LDA therapy 5–7 days before ESD until December 2010, when we instituted the new guidelines and performed ESD without interrupting LDA therapy. The aim of the present study was to confirm the validity of the noninterrupted use of LDA inpatients undergoing ESD for colorectal tumors.


We studied 582 consecutive patients with 609 colorectal tumors who underwent ESD at Hiroshima University Hospital between January 2006 and July 2014. The patients comprised three groups: LDA-interrupted group (13 patients with 13 colorectal tumors), LDA-continued group (28 patients with 31 colorectal tumors), and no anticoagulant/antiplatelet group (541 patients with 565 colorectal tumors).


The en bloc resection rate was 100 % (13/13) in the LDA-interrupted group and 90.3 % (28/31) in the LDA-continued group. Incidences of poor bleeding control during the procedure and bleeding after the procedure were 7.7 % (1/13) and 15.4 % (2/13) of patients, respectively, in the LDA-interrupted group, and 3.2 % (1/31) and 16.1 % (5/31) of patients, respectively, in the LDA-continued group. No patients experienced ischemic events in the perioperative period.


Our data suggest that continued use of LDA increased the risk of bleeding after ESD for colorectal tumors compared with nonuse of anticoagulant/antiplatelets. No significant difference was seen between the LDA-continued group and the LDA-interrupted group.


Colorectal tumor ESD Low-dose aspirin Bleeding Complication 


Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Tanaka S, Oka S, Chayama K, et al. Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection. J Gastroenterol. 2008;43:641–51.CrossRefPubMedGoogle Scholar
  2. 2.
    Tanaka S, Oka S, Kaneko I, et al. Endoscopic submucosal dissection for colorectal neoplasia: possibility of standardization. Gastrointest Endosc. 2007;66:100–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Yahagi N, Fujishiro M, Omata M. Endoscopic submucosal dissection of colorectal lesion. Dig Endosc. 2004;16(Suppl 2):S178–81.CrossRefGoogle Scholar
  4. 4.
    Tamegai Y, Saito Y, Masaki N, et al. Endoscopic submucosal dissection: a safe technique for colorectal tumors. Endoscopy. 2007;39:418–22.CrossRefPubMedGoogle Scholar
  5. 5.
    Saito Y, Uraoka T, Matsuda T, et al. Endoscopic treatment of large superficial colorectal tumors: a case series of 200 endoscopic submucosal dissections (with video). Gastrointest Endosc. 2007;66:966–73.CrossRefPubMedGoogle Scholar
  6. 6.
    Saito Y, Uraoka T, Yamaguchi Y, et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc. 2010;72:1217–25.CrossRefPubMedGoogle Scholar
  7. 7.
    Tanaka S, Terasaki M, Kanao H, et al. Current status and future perspectives of endoscopic submucosal dissection for colorectal tumors. Dig Endosc. 2012;24(Suppl 1):73–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Tanaka S, Terasaki M, Hayashi N, et al. Warning for unprincipled colorectal endoscopic submucosal dissection: accurate diagnosis and reasonable treatment strategy. Dig Endosc. 2013;25:107–16.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849–60.CrossRefPubMedGoogle Scholar
  10. 10.
    Yasue H, Ogawa H, Tanaka H, et al. Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators. Am J Cardiol. 1999;83:1308–13.CrossRefPubMedGoogle Scholar
  11. 11.
    Maulaz AB, Bezerra DC, Michel P, et al. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005;62:1217–20.CrossRefPubMedGoogle Scholar
  12. 12.
    Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27:2667–74.CrossRefPubMedGoogle Scholar
  13. 13.
    Anderson MA, Ben-Menachem T, Gan SI, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009;70:1060–70.CrossRefPubMedGoogle Scholar
  14. 14.
    Boustière C, Veitch A, Vanbiervliet G, et al. Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2011;43:445–61.CrossRefPubMedGoogle Scholar
  15. 15.
    Veitch AM, Baglin TP, Gershlick AH, et al. Guidelines for the management of anticoagulants and antiplatelet therapy in patients undergoing endoscopic procedures. Gut. 2008;57:1322–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc. 2014;26:1–14.CrossRefPubMedGoogle Scholar
  17. 17.
    Higashiyama M, Oka S, Tanaka S, et al. Risk factors for bleeding after endoscopic submucosal dissection of gastric epithelial neoplasm. Dig Endosc. 2011;23:290–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Tajiri H, Kitano S. Complications associated with endoscopic mucosal resection: definition of bleeding that can be viewed as accidental. Dig Endosc. 2004;16(Suppl 1):S134–6.CrossRefGoogle Scholar
  19. 19.
    Uraoka T, Higashi R, Kato J, et al. Colorectal endoscopic submucosal dissection for elderly patients at least 80 years of age. Surg Endosc. 2011;25:3000–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Probst A, Golger D, Anthuber M, et al. Endoscopic submucosal dissection in large sessile lesions of the rectosigmoid: learning curve in a European center. Endoscopy. 2012;44:660–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Tanaka S, Tamegai Y, Tsuda S, et al. Multicenter questionnaire survey on the current situation of colorectal endoscopic submucosal dissection in Japan. Dig Endosc. 2010;22(Suppl 1):S2–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Terasaki M, Tanaka S, Shigita K, et al. Risk factors for delayed bleeding after endoscopic submucosal dissection for colorectal neoplasms. Int J Colorectal Dis. 2014;29:877–82.CrossRefPubMedGoogle Scholar
  23. 23.
    Kobayashi N, Yoshitake N, Hirahara Y, et al. Matched case-control study comparing endoscopic submucosal dissection and endoscopic mucosal resection for colorectal tumors. J Gastroenterol Hepatol. 2012;27:728–33.CrossRefPubMedGoogle Scholar
  24. 24.
    Nakajima T, Saito Y, Tanaka S, et al. Current status of endoscopic resection strategy for large, early colorectal neoplasia in Japan. Surg Endosc. 2013;27:3262–70.CrossRefPubMedGoogle Scholar
  25. 25.
    Fujishiro M, Yahagi N, Kakushima N, et al. Outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms in 200 consecutive cases. Clin Gastroenterol Hepatol. 2007;5:678–83.CrossRefPubMedGoogle Scholar
  26. 26.
    Isomoto H, Nishiyama H, Yamaguchi N, et al. Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy. 2009;41:679–83.CrossRefPubMedGoogle Scholar
  27. 27.
    Watabe H, Yamaji Y, Okamoto M, et al. Risk assessment for delayed hemorrhagic complication of colonic polypectomy: polyp-related factors and patient-related factors. Gastrointest Endosc. 2006;64:73–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Fujita M, Shiotani A, Murao T, et al. Safety of gastrointestinal endoscopic biopsy in patients taking antithrombotics. Dig Endosc. 2014 (Epub ahead of print).Google Scholar
  29. 29.
    Hui AJ, Wong RM, Ching JY, et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc. 2004;59:44–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Manocha D, Singh M, Mehta N, et al. Bleeding risk after invasive procedures in aspirin/NSAID users: polypectomy study in veterans. Am J Med. 2012;12:1222–7.CrossRefGoogle Scholar
  31. 31.
    Metz AJ, Bourke MJ, Moss A, et al. Factors that predict bleeding following endoscopic mucosal resection of large colonic lesions. Endoscopy. 2011;43:506–11.CrossRefPubMedGoogle Scholar
  32. 32.
    Sanomura Y, Oka S, Tanaka S, et al. Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer. Gastric Cancer. 2014;17:489–96.PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Liaquat H, Rohn E, Rex DK. Prophylactic clip closure reduced the risk of delayed postpolypectomy hemorrhage: experience in 277 clipped large sessile or flat colorectal lesions and 247 control lesions. Gastrointest Endosc. 2013;77:401–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Matsumoto M, Fukunaga S, Saito Y, et al. Risk factors for delayed bleeding after endoscopic resection for large colorectal tumors. Jpn J Clin Oncol. 2012;42:1028–34.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan 2015

Authors and Affiliations

  • Yuki Ninomiya
    • 1
  • Shiro Oka
    • 1
    Email author
  • Shinji Tanaka
    • 1
  • Soki Nishiyama
    • 2
  • Yuzuru Tamaru
    • 2
  • Naoki Asayama
    • 2
  • Kenjiro Shigita
    • 2
  • Nana Hayashi
    • 2
  • Kazuaki Chayama
    • 2
  1. 1.Department of EndoscopyHiroshima University HospitalHiroshimaJapan
  2. 2.Department of Gastroenterology and MetabolismHiroshima University HospitalHiroshimaJapan

Personalised recommendations